Journal article
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
Emerging infectious diseases, Vol.27(5), pp.1472-1476
05/2021
DOI: 10.3201/eid2705.204056
PMCID: PMC8084512
PMID: 33900908
Abstract
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
Details
- Title: Subtitle
- Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
- Creators
- Abeer N AlshukairiJincun Zhao - First Affiliated Hospital of Guangzhou Medical UniversityMaha A Al-MozainiYanqun WangAshraf DadaSalim A BaharoonSara AlfarajWaleed A AhmedMushira A EnaniFatehi E ElzeinNazik EltayebLaila LayqahAiman El-SaedHusam A BahauddenAbdul HaseebSherif A El-KafrawyAhmed M HassanNajlaa A SiddiqIbtihaj AlsharifIsamel QushmaqEsam I AzharStanley PerlmanZiad A Memish
- Resource Type
- Journal article
- Publication Details
- Emerging infectious diseases, Vol.27(5), pp.1472-1476
- DOI
- 10.3201/eid2705.204056
- PMID
- 33900908
- PMCID
- PMC8084512
- NLM abbreviation
- Emerg Infect Dis
- ISSN
- 1080-6040
- eISSN
- 1080-6059
- Publisher
- United States
- Grant note
- P01 AI060699 / NIAID NIH HHS
- Language
- English
- Date published
- 05/2021
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Infectious Disease (Pediatrics)
- Record Identifier
- 9984071982302771
Metrics
23 Record Views